SCHEMBL22497648

SCHEMBL22497648

C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)ccc1N(C)CCN(C)C

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.77
ALK Q9UM73 8/20 0.77
EML4 Q9HC35 5/20 0.77
JAK3 P52333 7/20 0.57
JAK2 O60674 2/20 0.57
JAK1 P23458 2/20 0.57
TYK2 P29597 2/20 0.57
NUAK1 O60285 1/20 0.57
FLT3 P36888 1/20 0.57
CDK16 Q00536 1/20 0.57
CCNY Q8ND76 1/20 0.57
PTK2 Q05397 3/20 0.56
ERBB2 P04626 1/20 0.56
INSR P06213 1/20 0.56
ROS1 P08922 1/20 0.56
FER P16591 1/20 0.56
LTK P29376 1/20 0.56
BLK P51451 1/20 0.56
BTK Q06187 1/20 0.56
TNK2 Q07912 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22520143 0.92 EGFR (0.65) EGFRALKEML4JAK3JAK2
SCHEMBL22520220 0.91 EGFR (0.77) EGFRALKEML4JAK3JAK2
Hydrochloric Acid SCHEMBL29783050 0.91 EGFR (0.64) EGFRALKEML4JAK3JAK2
SCHEMBL22520100 0.89 EGFR (0.62) EGFRALKEML4JAK3JAK2
SCHEMBL22520157 0.88 JAK3 (0.61) EGFRALKEML4JAK3JAK2
SCHEMBL22497656 0.87 EGFR (1.00) EGFRALKEML4PTK2ERBB2
SCHEMBL22497633 0.86 EGFR (0.77) EGFRALKEML4
SCHEMBL28059271 0.86 EGFR (0.63) EGFRJAK3JAK2JAK1TYK2
SCHEMBL17766079 0.86 EGFR (0.79) EGFRALKEML4JAK3JAK2
SCHEMBL22520155 0.85 EGFR (0.59) EGFRALKEML4PTK2INSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020200191-A1 EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF BETTA PHARMACEUTICALS CO., LTD (CN) 2020-10-08 WO disclosed
WO-2020200191-A1 EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF BETTA PHARMACEUTICALS CO., LTD (CN) 2020-10-08 WO disclosed